Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
34.25
-0.70 (-2.00%)
Last updated: Jun 25, 2025
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 14.40 billion as of June 27, 2025. Its market cap has increased by 149.45% in one year.
Market Cap
14.40B
Enterprise Value
14.12B
Revenue
716.59M
Ranking
n/a
PE Ratio
153.44
Stock Price
34.25
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 14.40B, an increase of 74.34%. That is a compound annual growth rate of 18.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 14.40B | 126.82% |
Dec 31, 2024 | 6.35B | -8.63% |
Dec 29, 2023 | 6.95B | -9.56% |
Dec 30, 2022 | 7.68B | -6.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 344.23B |
Shenzhen Mindray Bio-Medical Electronics | 274.10B |
WuXi AppTec | 189.12B |
Zhangzhou Pientzehuang Pharmaceutical., | 120.95B |
Sichuan Biokin Pharmaceutical | 119.25B |
Aier Eye Hospital Group | 115.27B |
Shanghai United Imaging Healthcare | 105.13B |
Yunnan Baiyao Group Co.,Ltd | 99.70B |